Insights & Research

Expert perspectives on unlisted shares, pre-IPO opportunities, and wealth management strategies.

Unlisted Shares1 Jun 2026

API Holdings (PharmEasy) FY26 Deep Dive: From Billion-Rupee Losses to EBITDA Breakeven — And Why ₹6/Share Could Be a Historic Entry Point

API Holdings (PharmEasy) turns EBITDA positive in FY26 with ₹6,869 Cr revenue. At ₹6/share, is this India's best pre-IPO healthcare bet?

By Valowth CapitalRead more →